The Delhi High Court today said that no coercive steps be taken against drug companies for fixed dose combination (FDC)s already in market, subject to stopping of their manufacturing.
Justice Vibhu Bakhru granted relief to some drug manufacturers after they approached the High Court.
It had said earlier that no coercive steps be taken against Indian pharma major Wockhardt for sale of stock, already in the market, of its anti-inflammatory medicine which has been banned, subject to the company stopping further production of the drug.
The court, in an interim order, had said the medicine, one of 328 FDC drugs banned by the Centre a week ago, has been in the market for past 11 years and its stocks would already be in the distribution network.
The ministry by its September 7 notification had banned the manufacture, sale and distribution of 328 FDC drugs. FDCs are two or more drugs combined in a fixed ratio into a single dosage form.
Centre Bans 156 Combination Medicines Used For Fever, Pain, Cold Private Firm Employee Stabbed To Death By 2 Drug-Addict Men In Gurugram: Cops Donald Trump Promises To Reduce US Drug Prices To World's Lowest Amazon Employee Greets Friend At Wedding, Dies Of Cardiac Arrest This Asian City Is Emerging As Sex Tourism Hub. It's Not Where You Think Russia's Firing Of ICBM On Ukraine Is Weapon's 1st Combat Use In History PM Modi: Culture, Cuisine, Cricket Strengthen India-Guyana Ties Elon Musk Slams Australia's Plan To Ban Social Media For Kids Under 16 Assam Chief Minister Unveils These Facilities At Legislative Complex Track Latest News Live on NDTV.com and get news updates from India and around the world.